Flavin Mononucleotide as a Biomarker of Organ Quality—A Pilot Study

Flavin Mononucleotide as a Biomarker of Organ Quality—A Pilot Study

Background. Flavin mononucleotide (FMN), released from damaged mitochondrial complex I during hypothermic liver perfusion, has been shown to be predictive of 90-day graft loss. Normothermic machine perfusion (NMP) and normothermic regional perfusion (NRP) are used for organ reconditioning and qualit...

Full description

Bibliographic Details
Main Authors: Lu Wang, MRCS, Emily Thompson, MRCS, Lucy Bates, BSc, Thomas L. Pither, BSc, Sarah A. Hosgood, PhD, Michael L. Nicholson, DSc, Christopher J.E. Watson, MD, Colin Wilson, PhD, Andrew J. Fisher, PhD, Simi Ali, PhD, John H. Dark, FRCS
Format: Article
Language:English
Published: Wolters Kluwer 2020-09-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001046

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001046

Similar Items